Thomas Moriarty - Mar 15, 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP & General Counsel
Signature
/s/ Thomas M. Moriarty
Stock symbol
CVS
Transactions as of
Mar 15, 2022
Transactions value $
-$140,729
Form type
4
Date filed
3/17/2022, 04:32 PM
Previous filing
Feb 23, 2022
Next filing
Apr 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Sale -$5.39M -51.4K -5.78% $105.00 837K Mar 15, 2022 Direct
transaction CVS Common Stock Options Exercise $5.25M +51.4K +6.14% $102.26 888K Mar 15, 2022 Direct F1
holding CVS Common Stock 81.2K Mar 15, 2022 By GRAT
holding CVS Common Stock (restricted) 8.01K Mar 15, 2022 Direct
holding CVS Stock Unit 46.5K Mar 15, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Options Exercise $0 -51.4K -100% $0.00* 0 Mar 15, 2022 Common Stock 51.4K $102.26 Direct F1, F2
holding CVS Stock Option 71.7K Mar 15, 2022 Common Stock 71.7K $104.82 Direct F3
holding CVS Stock Option 125K Mar 15, 2022 Common Stock 125K $78.05 Direct F4
holding CVS Stock Option 36.5K Mar 15, 2022 Common Stock 36.5K $62.21 Direct F5
holding CVS Stock Option 101K Mar 15, 2022 Common Stock 101K $54.19 Direct F6
holding CVS Stock Option 148K Mar 15, 2022 Common Stock 148K $58.34 Direct F7, F8
holding CVS Stock Option 155K Mar 15, 2022 Common Stock 155K $74.30 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales were effected pursuant to a Rule 10b5-1 plan.
F2 Option became exercisable in four equal annual installments, commencing 4/1/2016.
F3 Option became exercisable in four equal annual installments, commencing 4/1/2017.
F4 Option became exercisable in four equal annual installments, commencing 4/3/2018.
F5 Option became exercisable in four equal annual installments, commencing 4/1/2019.
F6 Option became exercisable in four equal annual installments, commencing 4/1/2020.
F7 The number of shares subject to the option were calculated using a 30-day average price.
F8 Option became exercisable in four equal annual installments, commencing 4/1/2021.
F9 Option becomes exercisable in four equal installments, commencing 4/1/2022.